Home Medical stocks Is BenQ Medical Technology Corporation (GTSM:4116) An Attractive Dividend Stock? – Simply...

Is BenQ Medical Technology Corporation (GTSM:4116) An Attractive Dividend Stock? – Simply Wall St News

27
0

Dividend paying stocks like BenQ Medical Technology Corporation (GTSM:4116) tend to be popular with investors, and for good reason – some research suggests a significant amount of all stock market returns come from reinvested dividends. If you are hoping to live on your dividends, it’s important to be more stringent with your investments than the average punter. Regular readers know we like to apply the same approach to each dividend stock, and we hope you’ll find our analysis useful.

With BenQ Medical Technology yielding 4.1% and having paid a dividend for over 10 years, many investors likely find the company quite interesting. We’d guess that plenty of investors have purchased it for the income. The company also bought back stock during the year, equivalent to approximately 0.7% of the company’s market capitalisation at the time. Some simple analysis can offer a lot of insights when buying a company for its dividend, and we’ll go through this below.

Click the interactive chart for our full dividend analysis

historic-dividend
GTSM:4116 Historic Dividend August 20th 2020

Payout ratios

Dividends are usually paid out of company earnings. If a company is paying more than it earns, then the dividend might become unsustainable – hardly an ideal situation. As a result, we should always investigate whether a company can afford its dividend, measured as a percentage of a company’s net income after tax. Looking at the data, we can see that 101% of BenQ Medical Technology’s profits were paid out as dividends in the last 12 months. Unless there are extenuating circumstances, from the perspective of an investor who hopes to own the company for many years, a payout ratio of above 100% is definitely a concern.

We also measure dividends paid against a company’s levered free cash flow, to see if enough cash was generated to cover the dividend. BenQ Medical Technology paid out 103% of its free cash last year. Cash flows can be lumpy, but this dividend was not well covered by cash flow. Cash is slightly more important than profit from a dividend perspective, but given BenQ Medical Technology’s payouts were not well covered by either earnings or cash flow, we would definitely be concerned about the sustainability of this dividend.

With a strong net cash balance, BenQ Medical Technology investors may not have much to worry about in the near term from a dividend perspective.

We update our data on BenQ Medical Technology every 24 hours, so you can always get our latest analysis of its financial health, here.

Dividend Volatility

From the perspective of an income investor who wants to earn dividends for many years, there is not much point buying a stock if its dividend is regularly cut or is not reliable. For the purpose of this article, we only scrutinise the last decade of BenQ Medical Technology’s dividend payments. The dividend has been cut on at least one occasion historically. During the past 10-year period, the first annual payment was NT$1.2 in 2010, compared to NT$1.4 last year. This works out to be a compound annual growth rate (CAGR) of approximately 1.2% a year over that time. BenQ Medical Technology’s dividend payments have fluctuated, so it hasn’t grown 1.2% every year, but the CAGR is a useful rule of thumb for approximating the historical growth.

It’s good to see some dividend growth, but the dividend has been cut at least once, and the size of the cut would eliminate most of the growth, anyway. We’re not that enthused by this.

Dividend Growth Potential

With a relatively unstable dividend, it’s even more important to see if earnings per share (EPS) are growing. Why take the risk of a dividend getting cut, unless there’s a good chance of bigger dividends in future? It’s not great to see that BenQ Medical Technology’s have fallen at approximately 8.3% over the past five years. Declining earnings per share over a number of years is not a great sign for the dividend investor. Without some improvement, this does not bode well for the long term value of a company’s dividend.

Conclusion

When we look at a dividend stock, we need to form a judgement on whether the dividend will grow, if the company is able to maintain it in a wide range of economic circumstances, and if the dividend payout is sustainable. BenQ Medical Technology paid out almost all of its cash flow and profit as dividends, leaving little to reinvest in the business. Earnings per share have been falling, and the company has cut its dividend at least once in the past. From a dividend perspective, this is a cause for concern. In this analysis, BenQ Medical Technology doesn’t shape up too well as a dividend stock. We’d find it hard to look past the flaws, and would not be inclined to think of it as a reliable dividend-payer.

Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. However, there are other things to consider for investors when analysing stock performance. Just as an example, we’ve come accross 3 warning signs for BenQ Medical Technology you should be aware of, and 1 of them is potentially serious.

Looking for more high-yielding dividend ideas? Try our curated list of dividend stocks with a yield above 3%.

Promoted
If you’re looking to trade BenQ Medical Technology, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].

The easiest way to discover new investment ideas

Save hours of research when discovering your next investment with Simply Wall St. Looking for companies potentially undervalued based on their future cash flows? Or maybe you’re looking for sustainable dividend payers or high growth potential stocks. Customise your search to easily find new investment opportunities that match your investment goals. And the best thing about it? It’s FREE. Click here to learn more.

https://simplywall.st/stocks/tw/healthcare/gtsm-4116/benq-medical-technology-shares/news/is-benq-medical-technology-corporation-gtsm4116-an-attractive-dividend-stock/
https://simplywall.st/stocks/tw/healthcare/gtsm-4116/benq-medical-technology-shares/news/is-benq-medical-technology-corporation-gtsm4116-an-attractive-dividend-stock/

This site uses Akismet to reduce spam. Learn how your comment data is processed.